Whole body pharmacokinetic models

I Nestorov - Clinical pharmacokinetics, 2003 - Springer
The aim of the current review is to summarise the present status of physiologically based
pharmacokinetic (PBPK) modelling and its applications in drug research, and thus serve as …

Multiple peaking phenomena in pharmacokinetic disposition

NM Davies, JK Takemoto, DR Brocks… - Clinical pharmacokinetics, 2010 - Springer
Abstract multiple peaking in the blood fluid concentration-time curve is a phenomenon
occasionally encountered in pharmacokinetics. When it occurs, it can create difficulties in the …

[图书][B] Basic pharmacokinetics

MA Hedaya - 2012 - books.google.com
Knowledge of pharmacokinetics is critical to understanding the absorption, distribution,
metabolism, and excretion of drugs. It is therefore vital to those engaged in the discovery …

An evaluation of the utility of physiologically based models of pharmacokinetics in early drug discovery

N Parrott, N Paquereau, P Coassolo, T Lavé - Journal of pharmaceutical …, 2005 - Elsevier
Generic physiologically-based models of pharmacokinetics were evaluated for early drug
discovery. Plasma profiles after intravenous and oral dosing were simulated in rat for 68 …

Prediction of the volume of distribution of a drug: which tissue-plasma partition coefficients are needed?

S Björkman - Journal of pharmacy and pharmacology, 2002 - academic.oup.com
The aim of this study was to identify the tissue-plasma partition coefficients (Kp) needed for
an initial prediction of the volume of distribution at steady state (Vdss) of a drug in humans …

Quantitative structure-pharmacokinetics relationships: I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics …

GE Blakey, IA Nestorov, PA Arundel, LJ Aarons… - … of pharmacokinetics and …, 1997 - Springer
As pan of an overall program to develop a framework for evaluating the contribution of
structural and physicochemical properties to pharmacokinetics, the distribution kinetics of …

An introduction to physiologically‐based pharmacokinetic models

RN Upton, DJR Foster, AY Abuhelwa - Pediatric Anesthesia, 2016 - Wiley Online Library
Physiologically‐based pharmacokinetic (PBPK) models represent drug kinetics in one or
more 'real'organs (and hence require submodels of organs/tissues) and they describe …

Evaluating the pharmacokinetics of fentanyl in the brain extracellular fluid, saliva, urine, and plasma of newborns from transplacental exposure from parturient mothers …

MM Alsmadi - European Journal of Drug Metabolism and …, 2023 - Springer
Abstract Background and Objective Fentanyl can mitigate the mother and newborn
complications resulting from labor pain. However, fentanyl shows a narrow therapeutic index …

Prediction of the disposition of midazolam in surgical patients by a physiologically based pharmacokinetic model

S Björkman, DR Wada, BM Berling, G Benoni - Journal of pharmaceutical …, 2001 - Elsevier
The aim of this study was to predict the disposition of midazolam in individual surgical
patients by physiologically based pharmacokinetic (PBPK) modeling and explore the causes …

Application of physiologic models to predict the influence of changes in body composition and blood flows on the pharmacokinetics of fentanyl and alfentanil in …

S Bjorkman, RD Wada, D Stanski - The Journal of the American …, 1998 - pubs.asahq.org
Background The influence of changes in the physiologic state of a patient on the disposition
of fentanyl and alfentanil is poorly understood. The aims of this study were to determine …